Hiroaki Shigeta is Director at MEDICINES CO /DE (MDCO). They have made 2 open-market trades across 1 company since 2012, most recently 2017-05-25.
CIK 0001113481
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDCO | SELL | 2016-07-11 | 2016-07-13 | $38.50 | $296K | -1.6% | +3.0% | +1.7% |
| MDCO | SELL | 2016-06-13 | 2016-07-13 | $36.76 | $735K | -1.6% | +3.0% | +1.7% |
| MDCO | SELL · 10b5-1 | 2015-06-08 | 2015-06-10 | $28.99 | $217K | -11.5% | -4.2% | -4.2% |
| MDCO | SELL · 10b5-1 | 2013-11-25 | 2013-11-27 | $37.19 | $634K | -11.5% | -4.2% | -4.2% |
| MDCO | SELL · 10b5-1 | 2013-03-26 | 2013-03-28 | $33.50 | $863K | -11.5% | -4.2% | -4.2% |
| MDCO | SELL · 10b5-1 | 2012-04-25 | 2012-04-27 | $21.50 | $591K | -11.5% | -4.2% | -4.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.